Early Drug Discovery and Development of Novel Cancer Therapeutics Targeting DNA Polymerase Eta (POLH)
Polymerase eta (or Pol η or POLH) is a specialized DNA polymerase that is able to bypass certain blocking lesions, such as those generated by ultraviolet radiation (UVR) or cisplatin, and is deployed to replication foci for translesion synthesis as part of the DNA damage response (DDR). Inherited de...
Saved in:
Main Authors: | David M. Wilson, Matthew A. J. Duncton, Caleb Chang, Christie Lee Luo, Taxiarchis M. Georgiadis, Patricia Pellicena, Ashley M. Deacon, Yang Gao, Debanu Das |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/40bb23ee3ada4b41a46d7f5aa6c07ebc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DockStream: a docking wrapper to enhance de novo molecular design
by: Jeff Guo, et al.
Published: (2021) - Drug discoveries & therapeutics
-
Novel Antimicrobials from Uncultured Bacteria Acting against <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
by: Jeffrey Quigley, et al.
Published: (2020) -
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021) -
Radioligands Targeting Fibroblast Activation Protein (FAP)
by: Thomas Lindner, et al.
Published: (2021)